Patents by Inventor TIMOTHY BOYD

TIMOTHY BOYD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING COGNITIVE IMPAIRMENT
    Publication number: 20210106654
    Abstract: The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fins-related tyrosine kinase 3 (Fltt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1 alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.
    Type: Application
    Filed: July 24, 2020
    Publication date: April 15, 2021
    Applicant: University of South Florida
    Inventors: HUNTINGTON POTTER, GARY W. ARENDASH, STEVEN BENNETT, TIMOTHY BOYD
  • METHODS OF TREATING COGNITIVE IMPAIRMENT
    Publication number: 20170368142
    Abstract: The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fms-related tyrosine kinase 3 (Flt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.
    Type: Application
    Filed: July 10, 2017
    Publication date: December 28, 2017
    Inventors: HUNTINGTON POTTER, TIMOTHY BOYD, HEATHER SEVEY LAWRENCE JIM
  • METHODS OF TREATING COGNITIVE IMPAIRMENT
    Publication number: 20170189490
    Abstract: The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fms-related tyrosine kinase 3 (Flt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.
    Type: Application
    Filed: March 15, 2017
    Publication date: July 6, 2017
    Applicant: UNIVERSITY OF SOUTH FLORIDA
    Inventors: HUNTINGTON POTTER, GARY W. ARENDASH, STEVEN BENNETT, TIMOTHY BOYD
  • METHODS OF TREATING COGNITIVE IMPAIRMENT
    Publication number: 20150265678
    Abstract: The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fms-related tyrosine kinase 3 (Flt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.
    Type: Application
    Filed: June 4, 2015
    Publication date: September 24, 2015
    Inventors: HUNTINGTON POTTER, TIMOTHY BOYD, HEATHER SEVEY LAWRENCE JIM
  • METHODS OF TREATING COGNITIVE IMPAIRMENT
    Publication number: 20140255337
    Abstract: The subject invention concerns materials and methods for treating a person or animal having cognitive impairment. In one embodiment, the method comprises administering an effective amount of one or more inflammatory mediator(s), for example, fms-related tyrosine kinase 3 (Flt3) ligand, interleukin-6 (IL-6), macrophage migration inhibitory factor (MIF), interleukin-1 (IL-1), interleukin-3 (IL-3), erythropoietin (EPO), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible transcription factor (HIF-1alpha), insulin like growth factor-1 (IGF-1), tumor necrosis factor (TNF), granulocyte colony-stimulating factor (G-CSF), granulocyte/macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), Stem Cell Factor (SCF), Darbepoetin (ARANESP), and metalloproteinases, to an animal or person in need of treatment.
    Type: Application
    Filed: December 31, 2013
    Publication date: September 11, 2014
    Applicant: UNIVERSITY OF SOUTH FLORIDA
    Inventors: HUNTINGTON POTTER, GARY W. ARENDASH, STEVEN BENNETT, TIMOTHY BOYD
  • MAGNETIC IMMUNOHISTOCHEMICAL STAINING DEVICE AND METHODS OF USE
    Publication number: 20090325223
    Abstract: The subject invention concerns a device for use in staining samples or tissues of interests on slides. The subject invention also concerns methods of using the device to stain a specimen on a slide or to detect antibody and proteins of interest of a tissue section.
    Type: Application
    Filed: June 24, 2009
    Publication date: December 31, 2009
    Inventor: TIMOTHY BOYD